Anti-SEPP1/ SELENOP/ SELP functional antibody
Anti-SEPP1/ SELENOP/ SELP functional antibody for cell culture, ELISA & in-vivo assay
Go to SELENOP/SELENOP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0464-Ab-1/ GM-Tg-hg-SE0464-Ab-2 | Anti-Human SELENOP monoclonal antibody | Human |
GM-Tg-rg-SE0464-Ab-1/ GM-Tg-rg-SE0464-Ab-2 | Anti-Rat SELENOP monoclonal antibody | Rat |
GM-Tg-mg-SE0464-Ab-1/ GM-Tg-mg-SE0464-Ab-2 | Anti-Mouse SELENOP monoclonal antibody | Mouse |
GM-Tg-cynog-SE0464-Ab-1/ GM-Tg-cynog-SE0464-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SELENOP monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0464-Ab-1/ GM-Tg-felg-SE0464-Ab-2 | Anti-Feline SELENOP monoclonal antibody | Feline |
GM-Tg-cang-SE0464-Ab-1/ GM-Tg-cang-SE0464-Ab-2 | Anti-Canine SELENOP monoclonal antibody | Canine |
GM-Tg-bovg-SE0464-Ab-1/ GM-Tg-bovg-SE0464-Ab-2 | Anti-Bovine SELENOP monoclonal antibody | Bovine |
GM-Tg-equg-SE0464-Ab-1/ GM-Tg-equg-SE0464-Ab-2 | Anti-Equine SELENOP monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0464-Ab-1/ GM-Tg-hg-SE0464-Ab-2; GM-Tg-rg-SE0464-Ab-1/ GM-Tg-rg-SE0464-Ab-2; GM-Tg-mg-SE0464-Ab-1/ GM-Tg-mg-SE0464-Ab-2; GM-Tg-cynog-SE0464-Ab-1/ GM-Tg-cynog-SE0464-Ab-2; GM-Tg-felg-SE0464-Ab-1/ GM-Tg-felg-SE0464-Ab-2; GM-Tg-cang-SE0464-Ab-1/ GM-Tg-cang-SE0464-Ab-2; GM-Tg-bovg-SE0464-Ab-1/ GM-Tg-bovg-SE0464-Ab-2; GM-Tg-equg-SE0464-Ab-1/ GM-Tg-equg-SE0464-Ab-2 |
Products Name | Anti-SELENOP monoclonal antibody |
Format | mab |
Target Name | SELENOP |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SELENOP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0464-Ag-1 | Recombinant multi-species SEPP1/ SELENOP/ SELP protein |
ORF Viral Vector | vGMLV000211 | human SELENOP Lentivirus particle |
ORF Viral Vector | vGMLP001256 | human SELENOP Lentivirus particle |
ORF Viral Vector | pGMLP001256 | human SELENOP Lentivirus plasmid |
ORF Viral Vector | pGMLV000211 | human SELENOP Lentivirus plasmid |
ORF Viral Vector | pGMLPm001843 | mouse Selenop Lentivirus plasmid |
ORF Viral Vector | vGMLPm001843 | mouse Selenop Lentivirus particle |
Target information
Target ID | GM-SE0464 |
Target Name | SELENOP |
Gene ID | 6414,20363,29360,698917,479346,101093246,282066,100052968 |
Gene Symbol and Synonyms | D15Ucla1,Se-P,SELENOP,SELP,SeP,SEPP,SEPP1 |
Uniprot Accession | P49908,P25236,P49907 |
Uniprot Entry Name | SEPP1_HUMAN,SEPP1_RAT,SEPP1_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000250722 |
Target Classification | Tumor-associated antigen (TAA) |
The target: SELENOP, gene name: SELENOP, also named as SELP, SEPP, SEPP1, SeP. This gene encodes a selenoprotein that is predominantly expressed in the liver and secreted into the plasma. This selenoprotein is unique in that it contains multiple selenocysteine (Sec) residues per polypeptide (10 in human), and accounts for most of the selenium in plasma. It has been implicated as an extracellular antioxidant, and in the transport of selenium to extra-hepatic tissues via apolipoprotein E receptor-2 (apoER2). Mice lacking this gene exhibit neurological dysfunction, suggesting its importance in normal brain function. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. The mRNA for this selenoprotein contains two SECIS elements. The use of alternative polyadenylation sites, one located in between the two SECIS elements, results in two populations of mRNAs containing either both (predominant) or just the upstream SECIS element (PMID:27881738). Alternatively spliced transcript variants have also been found for this gene. [provided by RefSeq, Oct 2018].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.